SUMMARY A retrospective study of the effects of argon laser trabeculoplasty on a consecutive series of 44 phakic patients (55 eyes) with exfoliation syndrome glaucoma is reported. The followup was 12 to 23 months, mean 15 months. At an individual level laser trabeculoplasty was successful in 70% of the patients and 40% were able to reduce or stop their medication. Two patients showed 'late failure' at 15 months after initial control. An early rise of intraocular pressure was fairly common in the exfoliation group, and perhaps these patients need particularly careful monitoring during the initial hours following argon laser trabeculoplasty. A beneficial effect was noted on diurnal curve fluctuations and peak intraocular pressures.
Several investigators have shown that argon laser trabeculoplasty (ALT) is an effective method of treatment in many patients with exfoliation syndrome glaucoma.`-It has been noted that the prognosis of exfoliation glaucoma patients treated either medically and/or surgically is poorer than that of simplex glaucoma patients. 45 This study retrospectively considers the results of ALT performed in 1982 at the University Hospital, Uppsala, on phakic patients with exfoliation syndrome glaucoma.
Materials and methods
A consecutive series of 44 phakic patients (55 eyes) with exfoliation syndrome were studied who received argon laser trabeculoplasty between January and December 1982. This allowed for a 12-to 24-month follow-up for each patient. Four cases with previous filtering surgery to the eye concerned were excluded.
Prior to laser treatment the patients were admitted to hospital and a diurnal pressure curve consisting of seven readings, performed with a Goldmann applanation tonometer, was plotted. Laser trabeculoplasty was performed by a coherent system argon laser, Lasertek 40A, to 1800 of the trabecular mesh- where 0-2 second was employed), and the power was adjusted to obtain a suitable end point for the individual. Seven different surgeons carried out the laser treatment of these patients.
After laser treatment the intraocular pressures were measured on the patients in hospital to detect any early pressure rise, and some patients were started on corticosteroid drops.
Subsequent pressure measurements were taken at various intervals, with the patient either in hospital, in which case a diurnal curve of seven readings were plotted, or as an outpatient, when either a single set of readings or three readings spread over a morning and afternoon were recorded. Only 11 eyes had diurnal curves plotted for more than six months after the laser therapy.
It was decided that the criteria used to judge 'success' of laser treatment in a given case would be two-fold, namely (1) an average fall in mean intraocular pressure of at least 20% from the baseline value; (2) in addition, no two consecutive intraocular pressures above 21 mmHg.
Two patients who by these criteria would be judged successful cases were excluded when classification into success or failure was considered, because their medication was increased between one and nine months after laser treatment. In one case of uniocular exfoliative glaucoma the acetazolamide was increased from 125 mg tds to 500 mg bd 9 months after ALT. At that time the intraocular pressure in each eye was 11 mmHg. In the other case guttae epinephrine (adrenaline) 1% was added to both eyes despite the intraocular pressure in the lasered eye 886 having fallen from a baseline mean of 23 to 17 mmHg at six weeks after laser treatment. The intraocular pressure estimations following the increase in medication were also not included in the study. One patient who by our criteria would be classified as a failure and who received an addition of acetazolamide 375 mg a day to his medical therapy was retained in the study because the increased medication was given secondary to poor control, and it was considered that this lack of control of intraocular pressure could not be discounted without biasing the study.
Results
Fifty-five eyes of 44 patients had laser trabeculoplasty in 1982; the mean age of the group was 70-0. Twentyone of 55 eyes (38%) received only 1800 of argon laser trabeculoplasty rather than 360°in two sessions separated by a few weeks. Table 1 shows the effect of ALT on the mean intraocular pressure, the peak intraocular pressure, and the pressure irregularity of the diurnal curve.
This last was given by the standard deviation of the seven pressure readings from the mean measured over the 24-hour period. A composite reading for each patient consisting of all pressure recordings from one to six months after ALT and also a composite of the 9, 12, and 15 month readings are shown in the table, but the individual timed results are seen in Figs. 1 and 2. A one-tailed paired t test was performed, and the decrease in the mean IOP, the peak IOP, and pressure irregularity of the diurnal curve were all found to be significant (p<00005). Table 2 shows that 70% of patients could be classified as a success according to the above criteria, but of the subgroup with a baseline mean IOP of 21 mmHg or below only 30% qualified. A second method of classification for success, as defined by the peak intraocular pressure being 21 mmHg or less following ALT, was considered which may be particularly appropriate for these patients with low pretreatment intraocular pressures.
In Table 3 the reduction in medical therapy following the laser treatment is shown. The total number of different medications taken (pilocarpine, adrenaline, timolol, and carbonic anhydrase inhibitors) was used to assess this, and the few cases of small alterations in strength and dosage of a particular agent were ignored. 15% of patients were able to stop all antiglaucoma medical treatment and a further 25% to reduce the number of their medications. These results are demonstrated graphically in Fig. 3 . Table 4 shows the early spike in intraocular pressure that can occur in the 24 hours following ALT. The best parameter to consider is perhaps a comparison with the diurnal curve peak intraocular pressure in the 24 hours before laser treatment, and it is of note that there were six cases (7%) with an increase of 10 mmHg or greater. Many previous authors have used the immediate pretreatment reading as a baseline or the starting mean and thus an increase of pressure above the diurnal curve mean has also been shown. In this case 32 eyes (37% of laser treatments) had a pressure spike of 5 mmHg or greater, of which 14 (16%) were 10 mmHg or more above baseline. Table 5 shows that the total quantity of laser energy applied had little effect on success rate and also compares the results of those patients who received only 1800 ALT with the remainder. The mean interval between laser treatments was three weeks.
As far as the failure cases are concerned, three proceeded to trabeculectomy three to six months after laser treatment. Another patient showed a poor response for 10 months after the first 1800 ALT at which stage treatment of the remaining half of the trabecular meshwork was performed. This patient subsequently did well for the next eight months.
Two of the cases were a success for a year at least, but then control was lost at 15 months and they could be classified as 'late failures.' PEAK IOP mm Hg) 4- 32.. in mean intraocular pressure was despite a reduction in medical treatment in 40% of the eyes subjected to laser treatment. Analysis of the 24-hour diurnal curves showed a concomitant fall in peak intraocular pressure of 8.4 mmHg (28%) and a reduction in the irregularity of the pressure curve of 34% between one and six months following laser treatment. Greenidge et al. 6 have previously described a significant reduction in the mean peak pressure of 22% and in pressure fluctuation of 25% in diurnal curves of 25 patients with primary open angle glaucoma eight weeks after laser treatment. Here we see similar and if anything slightly greater improvements in the diurnal curves of exfoliation syndrome patients up to 12 months after ALT.
The average fall in mean intraocular pressure reached a maximum at three months of 8-0 mmHg and then decreased a little, so that at one year it was 6-7 mmHg and by 15 months 5 6 mmHg, though it did thereafter improve to 6-1 mmHg by 18 months (Fig. 1) . It is difficult to see whether there is a loss of effect of the laser treatment with time, as of course medical therapy was reduced or stopped in 40% of the eyes. Another factor confusing the issue is that the poor results of the three cases that proceeded to trabeculectomy are not included at the later time periods, which should theoretically lead to a marginal improvement in group results later on.
It can be seen from Table 5 that the amount of laser energy applied to the trabecular meshwork had no significant effect on the percentage of success of cases. The finding of slightly improved results of 80% success for the patients receiving 1800 laser compared with only 64% success for those receiving 2x 180°l aser is probably an artefact due to the fact that those patients who responded well did not have a second laser treatment. This impression is enhanced by the knowledge that patients receiving their second laser treatment within two weeks of the first-that is, before the effect of the first laser treatment could be fully determined-had an 80% success rate, like those receiving only 180°of laser compared with 38% for those three weeks or longer between treatments.
At an individual level, by our criteria of a fall in intraocular pressure of at least 20% and in addition no two consecutive IOPs above 21 mmHg, 70% of the treated group qualified so far as a success (mean follow-up 15 months). At one year this was even higher (74%), but two patients who initially showed well controlled intraocular pressures subsequently 'failed' at 15 months. This finding of late failure among the exfoliation glaucoma patients has been documented by Pohjanpelto who described it in 10 out of his 93 initially successful exfoliation cases.2 Wilensky and Weinreb7 also described two cases of late failure, one of which was a patient with exfoliation glaucoma.
The 10 patients who, with their medical therapy, had starting mean intraocular pressures of 21 mmHg or less showed only a 30% success rate by our criteria compared with a 79% success rate in those patients with a baseline intraocular pressure above 21 mmHg. In six out of the seven failures of this group classification was due to lack of the required 20% fall in intraocular pressure, the mean intraocular pressures remaining below 21 mmHg. It has been previously shown that the lower the intraocular pressure before laser the smaller is the decrease that can be expected both numerically and in percentage terms.38 It may therefore be unreasonable to apply the requirement of a 20% fall in intraocular pressure in this subgroup as a method of judging success. All 10 of these patients had elevated prelaser peak intraocular pressures (average 24-7 mmHg), and control of the peak pressure to 21 mmHg or below may be a better criterion of success for this subgroup. In these terms six (60%) could be graded 'successful.' As mentioned above, all patients received laser therapy to only 1800 of the meshwork at a time. In our study there were six cases of intraocular pressure rises of over 10 mmHg in the immediate posttreatment hours, five of the six occurring after the first 1800 laser session. Indeed one patient had a rise in pressure to over 60 mmHg from a starting peak intraocular pressure of 38 mmHg and required osmotic agents to relieve symptoms. It may further be noted that none of the 22 eyes (18 patients) with phakic chronic simple glaucoma who received ALT at the same department by the same surgeons between January and December 1982 had an early IOP rise of 10 mmHg or greater.
Weinreb et al.9 had only one of a mixed group of 20 patients treated with 180°ALT to the anterior meshwork who showed a pressure rise of 10 mmHg. Thomas et al.3 reported three of 102 eyes treated with 2x 1800 ALT to the posterior meshwork, with pressure elevation of greater than 10 mmHg above baseline. Neither of these papers compared pressure rises with peak baseline pressures. If a mean baseline pressure is considered, 14 cases (16%) of a pressure spike of 10 mmHg or greater were recorded, 11 of these occurring at the time of the first laser treatment. In view of these findings it would seem reasonable to suggest that exfoliation glaucoma patients should be even more closely monitored than others in the initial hours following ALT. 
